| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10910948 | Lung Cancer | 2015 | 6 Pages |
Abstract
To the best of our knowledge, this is the largest-scale study to evaluate PD-L1 expression in thymomas and thymic carcinomas. The data suggest that the anti PD-1/PD-L1 drug could be of potential use in immunotherapy for unresectable or relapsed thymomas and thymic carcinomas.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Yuki Katsuya, Yu Fujita, Hidehito Horinouchi, Yuichiro Ohe, Shun-ichi Watanabe, Koji Tsuta,